Federal Appeals Court Blocks Mail Access to Mifepristone, Impacting Abortion Access
A federal appeals court has issued a ruling that prevents the distribution of mifepristone abortion pills through the mail, a decision expected to significantly restrict abortion access in states where it is banned. The U.S. 5th Circuit Court of Appeals in New Orleans responded to a lawsuit from Louisiana, which challenged federal regulations allowing the mailing of mifepristone. Louisiana Attorney General Liz Murrill argued that the regulation led to illegal abortions and increased Medicaid costs. The court's decision blocks the FDA rule permitting mail distribution, citing that it undermines Louisiana's laws and increases Medicaid expenses due to emergency care for complications. The ruling is anticipated to be appealed to the Supreme Court. 
